Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study.

Frustaci, S; Buonadonna, A; Galligioni, E; Favaro, D; De Paoli, A; Lo Re, G; Sorio, R; Tumolo, S; Monfardini, S

Frustaci, S; Buonadonna, A; Galligioni, E; Favaro, D; De Paoli, A; Lo Re, G; Sorio, R; Tumolo, S; Monfardini, S.

Affiliation

Frustaci S; Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy. oncomed@ets.it

J Clin Oncol ; 15(4): 1418-26, 1997 Apr.

Article in En | MEDLINE | ID: mdl-9193334

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use; Hematopoiesis/drug effects; Sarcoma/drug therapy; Adult; Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Agents, Alkylating/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Doxorubicin/administration & dosage; Drug Administration Schedule; Female; Hematopoietic Stem Cells/drug effects; Humans; Ifosfamide/administration & dosage; Male; Middle Aged; Pilot Projects; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Antineoplastic Combined Chemotherapy Protocols / Granulocyte-Macrophage Colony-Stimulating Factor / Hematopoiesis Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1997 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links